PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17959037-11	2007	The positive rate of SSTR-2 in gastric cancers treated with celecoxib (48%) was significantly higher than that of control group (12%) after surgery (P<0.05).	Celecoxib	60-69	somatostatin receptor 2	Homo sapiens	21-27	
17959037-13	2007	NAG-1 and SSTR-2 might be the molecular targets for celecoxib or octreotide.	Celecoxib	52-61	somatostatin receptor 2	Homo sapiens	10-16